# Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users

> **NCT00977249** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 200 (estimated)

## Conditions studied

- Tobacco Dependence

## Interventions

- **BEHAVIORAL:** support and visits
- **DRUG:** varenicline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00977249
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977249, "Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00977249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*